Annual report pursuant to Section 13 and 15(d)

Restatement of financial statements (Tables)

v2.4.0.8
Restatement of financial statements (Tables)
12 Months Ended
Dec. 31, 2012
Notes to Financial Statements  
Summary of reported net income to restated amounts

The following table reconciles previously reported net income to restated amounts:

                                                                                                                                                        

   

Year Ended

December 31,

2012

   

Year Ended

December 31,

2011

   

Total

Cumulative Adjustments

December 31,

2012

 
    $     $     $  
Net (loss) and comprehensive loss                  
As Previously Reported (Note 2a)     (429,177 )     (3,637,564 )      
Adjustment on previous reported impairment on long term investment             531,334       531,334  
As Restated     (429,177 )     (3,106,230 )        

Selected Consolidated Balance Sheet information

Selected Consolidated Balance Sheet information as of December 31, 2012

 

   

Previously

Reported

   

Increase

(Decrease)

    Restated  
    $     $     $  
Assets                  
Long-term investment     2,267,252       (2,267,252 )     -  
                         
Total Assets     2,433,881       (2,267,252 )     166,629  
                         
Stockholders’ equity (deficiency)                        
Additional Paid in Capital     8,589,249       (2,798,586 )     5,790,663  
Deficit     (6,429,213 )     531,334       (5,897,879 )
                         
Total Stockholders’ Equity (Deficiency)     2,186,361       (2,267,252 )     (80,891 )
Total Liabilities and stockholders’ equity (deficiency)     2,433,881       (2,267,252 )     166,629  

 

 

Selected Consolidated Balance Sheet information as of December 31, 2011

 

   

Previously

Reported

   

Increase

(Decrease)

    Restated  
    $     $     $  
Assets                        
Long-term investment     2,267,252       (2,267,252 )     -  
                         
Total Assets     2,275,916       (2,267,252 )     8,664  
                         
Stockholders’ Equity                        
Additional Paid in Capital     8,227,046       (2,798,586 )     5,428,460  
Deficit accumulated during the                        
Development stage     (4,692,969 )     531,334       (4,161,635 )
                         
Total Stockholders’ Equity (Deficiency)     2,247,177       (2,267,252 )     (20,075 )
                         
Total Liabilities and stockholders’ equity (deficiency)     2,275,916       (2,267,252 )     8,664  

 

Selected Consolidated Statement of Operations and Comprehensive Loss

Selected Consolidated Statement of Operations and Comprehensive Loss for the year ended December 31, 2011

                                                                                           

   

Previously

Reported

   

Increase

(Decrease)

    Restated  
    $     $     $  
Impairment loss on long-term investment     2,798,586       (531,334 )     2,267,252  
Loss before other items     (3,637,578 )     531,334       (3,106,244 )
Loss from continuing operations     (3,637,564 )     531,334       (3,106,230 )
Net Loss and Comprehensive Loss     (3,637,564 )     531,334       (3,106,230 )
Basic and diluted loss per common share     (0.84 )     0.12       (0.72 )

 

Selected Consolidation Statements of Cash Flows information

Selected Consolidation Statements of Cash Flows information for the year ended December 31, 2011

 

   

Previously

Reported

   

Increase

(Decrease)

    Restated  
    $     $     $  
Net loss     (3,637,564 )     531,334       (3,106,230 )
Impairment loss on long term investment     2,798,586       (531,334 )     2,267,252